Search results
We strive to conquer epilepsies and brain conditions with courageous science. We are developing a next generation of targeted small molecule therapies that seek to reduce seizures and deliver improved safety and tolerability.
- Community Guidelines
As of January 6, 2019 Thank you for your interest in Ovid...
- SEC Filings
At Ovid Therapeutics Inc., we promise to treat your data...
- Governance Documents
At Ovid Therapeutics Inc., we promise to treat your data...
- Our Story
Ovid Therapeutics is a biopharmaceutical company striving to...
- Our Pipeline
We are cultivating a differentiated pipeline of small...
- Investor Relations
Ovid Therapeutics is a New York-based biopharmaceutical...
- Community Guidelines
Find the latest Ovid Therapeutics Inc. (OVID) stock quote, history, news and other vital information to help you with your stock trading and investing.
Ovid Therapeutics is a biopharmaceutical company striving to calm the storm that causes seizures by developing new medicines for epilepsies and brain conditions. Today, nearly 50 million people across the world live with epilepsies and seizures.
We are cultivating a differentiated pipeline of small molecule medicines that utilize first-in-class or potential best-in-class mechanisms of action (MoAs) to reduce the neuronal hyperexcitability that underlies debilitating brain conditions including epilepsy.
17 cze 2024 · NEW YORK, June 17, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to meaningfully improving the lives of people affected by rare epilepsies and brain conditions, reports that Takeda Pharmaceutical Company Limited (Takeda) has announced topline data from its Phase 3 SKYLINE and SKYWAY ...
Ovid Therapeutics is a biopharmaceutical company striving to calm the storm that causes seizures by developing new medicines for epilepsies and brain conditions. For those who need relief, we...
26 wrz 2024 · Ovid Therapeutics is a New York-based biopharmaceutical company striving to conquer epilepsies and seizures with courageous science. Ovid is developing a pipeline of potential small molecule medicines that seek to meaningfully improve the lives of those affected by rare epilepsies and disorders with seizure symptoms.
